BRISTOL TENNESSEE BASED KING PHARMACEUTICALS HAS EXTENDED ITS PREVIOUSLY ANNOUNCED TENDER OFFER FOR ALL OUTSTANDING SHARES OF ALPHARMA INCORPORATED. THE OFFER WILL LAST THROUGH 5 P.M. ON NOVEMBER 21ST. ON SEPTEMBER 12TH, KING ANNOUNCED IT HAD PLACED A TENDER OFFER TO ACQUIRE ALL THE OUTSTANDING SHARES OF ALPHARMA FOR 37 DOLLARS PER SHARE IN CASH. ALPHARMA SHAREHOLDERS DECIDED AGAINST THE OFFER. NOW, KING HAS DECIDED TO EXTEND THE PREVIOUS OFFER ONCE AGAIN.